Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Replimune Group, Inc. (REPL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 18,600 shares @ $20.01, valued at $372.2k
Exercised 13,600 options to buy @ $3.3, valued at $44.9k
Exercised 5,000 options to buy @ $15.5, valued at $77.5k
08/15/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 1,400 shares @ $20, valued at $28k
Exercised 1,400 options to buy @ $3.3, valued at $4.6k
07/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2023 4 Lewis Tanya (Chief Dev. Op. Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 12,043 shares @ $24.1, valued at $290.2k
Sold 817 shares @ $23.45, valued at $19.2k
06/15/2023 4 Patel Sushil (Chief Strategy Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 5,145 shares @ $24.11, valued at $124k
Sold 553 shares @ $23.44, valued at $13k
05/18/2023 4 Patel Sushil (Chief Strategy Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 15,575 shares @ $18.05, valued at $281.1k
05/18/2023 4 Coffin Robert (President & Chief R&D Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 7,861 shares @ $18.05, valued at $141.9k
05/18/2023 4 Lewis Tanya (Chief Dev. Op. Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 12,207 shares @ $18.05, valued at $220.3k
05/18/2023 4 Love Colin (COO) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 10,775 shares @ $18.05, valued at $194.5k
05/18/2023 4 Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 11,351 shares @ $18.05, valued at $204.9k
05/18/2023 4 Xynos Konstantinos (Chief Medical Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 771 shares @ $18.05, valued at $13.9k
05/18/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 5,966 shares @ $18.05, valued at $107.7k
05/18/2023 4 Astley-Sparke Philip (CEO) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 17,902 shares @ $18.05, valued at $323.1k
04/04/2023 4 Slootweg Hugo Alexander (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 25,200 options to buy @ $17.66, valued at $445k
04/04/2023 4 Pucci Paolo (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 25,200 options to buy @ $17.66, valued at $445k
04/04/2023 4 Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 25,200 options to buy @ $17.66, valued at $445k
04/04/2023 4 SLATTERY JOSEPH P (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 25,200 options to buy @ $17.66, valued at $445k
04/04/2023 4 Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 25,200 options to buy @ $17.66, valued at $445k
04/04/2023 4 Weinand Dieter (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 37,800 options to buy @ $17.66, valued at $667.5k
04/04/2023 4 Oliger Christy J. (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 25,200 options to buy @ $17.66, valued at $445k
04/04/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 40,000 shares @ $0
Granted 60,000 options to buy @ $17.66, valued at $1.1M
04/04/2023 4 Xynos Konstantinos (Chief Medical Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 50,000 shares @ $0
Granted 75,000 options to buy @ $17.66, valued at $1.3M
04/04/2023 4 Franchi Jean M. (CFO) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 45,000 shares @ $0
Granted 67,500 options to buy @ $17.66, valued at $1.2M
04/04/2023 4 Love Colin (COO) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 40,000 shares @ $0
Granted 60,000 options to buy @ $17.66, valued at $1.1M
04/04/2023 4 Lewis Tanya (Chief Dev. Op. Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 40,000 shares @ $0
Granted 60,000 options to buy @ $17.66, valued at $1.1M
04/04/2023 4 Patel Sushil (Chief Strategy Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 40,000 shares @ $0
Granted 60,000 options to buy @ $17.66, valued at $1.1M
04/04/2023 4 Coffin Robert (President & Chief R&D Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 45,000 shares @ $0
Granted 67,500 options to buy @ $17.66, valued at $1.2M
04/04/2023 4 Astley-Sparke Philip (CEO) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 142,100 shares @ $0
Granted 213,150 options to buy @ $17.66, valued at $3.8M
12/13/2022 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 15,000 shares @ $25.03, valued at $375.5k
Exercised 15,000 options to buy @ $1.01, valued at $15.2k
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Love Colin (COO) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 6,324 shares @ $14.59, valued at $92.3k
05/18/2022 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 3,507 shares @ $14.59, valued at $51.2k
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy